Treatments and procedures

Genesis is the only hospital in the region performing innovative and minimally-invasive procedures for cardiac care. These new technologies and techniques allow our highly-skilled physicians to care for your heart while reducing downtime, scarring and pain after a procedure:

• Impella® heart pump - The Impella® Percutaneous Hemodynamic Support Device is used in patients with heart failure and high-risk patients undergoing Percutaneous Intervention (PCI) stenting. Impella pumps blood from the left ventricle of the heart during a procedure to allow it to recover and rest.

• Lead extractions

• MitraClip™ - Is a minimally invasive procedure that can reduce the risk of heart failure and stroke for patients with mitral valve regurgitation. Our physicians use a tube to insert the MitraClip implant through a vein in your upper leg and guide it to your heart, where it is attached to your mitral valve to help it close properly and restore normal blood flow.

• Patent Foramen Ovale (PFO) closure - The procedure to close a hole in the heart, not detected at birth, takes a much different route than in the past when open-heart surgery was required to correct the opening. Our physicians use a catheter to enter blood vessels to reach the heart. Once there, the catheter guides a device called an occluder to the opening, allowing it to expand and close the hole.

• Robotic-assisted cardiac heart surgery - These minimally-invasive heart procedures being performed at Genesis include Coronary Artery Bypass Grafting (CABG) and cardiac tissue ablation. During a robotic-assisted CABG, the physician is able to make smaller incisions that expose only damaged arteries rather than the entire heart like traditional open-heart surgery.

• Thoracic Endovascular Aortic Repair (TEVAR)

• Transcatheter Aortic Valve Replacement (TAVR) - Uses advanced imaging and small catheters to replace diseased heart valves. Instead of a large incision to the chest, physicians performing TAVR use a flexible tube to guide a new valve through a blood vessel to the heart. TAVR is minimally invasive, meaning patients have less pain and experience faster recovery times – usually needing just an overnight stay in the hospital.

• Transcatheter Mitral Valve Replacement (MVR)

• WATCHMAN™ - This implant can reduce the risk of stroke and eliminate blood thinners for patients with atrial fibrillation (AFib) not caused by a heart valve problem. During a one-time, minimally invasive procedure, WATCHMAN is inserted through a small tube from a blood vessel in the leg to the heart where it closes the left atrial appendage. Patients typically return home the next day and may be able to stop blood thinners within 45 days.